Home > Financial Ratios > GLENMARK PHARMACEUTICALS

GLENMARK PHARMACEUTICALS
Cash Earnings per Share (CEPS)

    Back to All Ratios
GLENMARK PHARMACEUTICALS is part of below Screeners ↓
Best Quarterly Growth Mid Cap Stocks
Best 1M Momentum Mid Cap Stocks
COMMUNITY POLL
for GLENMARK PHARMACEUTICALS
Please provide your vote to see the results

GLENMARK PHARMACEUTICALS Last 5 Year Cash Earnings per Share (CEPS) History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023Mar2022
   CEPS(Rs) 68.5854.33-44.2617.0052.46

What is the latest Cash Earnings per Share (CEPS) ratio of GLENMARK PHARMACEUTICALS ?

The latest Cash Earnings per Share (CEPS) ratio of GLENMARK PHARMACEUTICALS is 68.58 based on Mar2026 Consolidated results.
Year Cash Earnings per Share (CEPS)
Mar202668.58
Mar202554.33
Mar2024-44.26
Mar202317.00
Mar202252.46

How is Cash Earnings per Share (CEPS) of GLENMARK PHARMACEUTICALS Trending?

Years Cash Earnings per Share (CEPS) % Change
Mar2026 68.58
26.23
Mar2025 54.33
Positive
Mar2024 -44.26
Negative
Mar2023 17
-67.59
Mar2022 52.46 -

Other Financial Ratios of GLENMARK PHARMACEUTICALS


Compare Cash Earnings per Share (CEPS) ratio of peers of GLENMARK PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GLENMARK PHARMACEUTICALS ₹69,308.3 Cr 6.5% 8.6% 25.7% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹455,994.0 Cr -0% -4.5% 15.9% Stock Analytics
DIVIS LABORATORIES ₹240,249.0 Cr 5.9% 16.1% 49.6% Stock Analytics
TORRENT PHARMACEUTICALS ₹191,135.0 Cr 3% 3% 34% Stock Analytics
CIPLA ₹114,708.0 Cr -0.4% -3.6% -11.6% Stock Analytics
DR REDDYS LABORATORIES ₹98,074.9 Cr NA 2.8% -7.1% Stock Analytics


GLENMARK PHARMACEUTICALS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
GLENMARK PHARMACEUTICALS

6.5%

8.6%

25.7%

SENSEX

-0.8%

0.2%

-6%


You may also like the below Video Courses